Rivaroxaban versus Enoxaparin for thromboprophylaxis after total knee arthroplasty

Abstrakt

We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in preventing venous thrombosis after total knee arthroplasty.